FindTrial
Sign In

Prediction of lateral cervical lymph node metastasis of papillary thyroid microcarcinoma

Prediction of lateral cervical lymph node metastasis of papillary thyroid microcarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069040
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-03-05
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

Gold Standard:Routine postoperative pathological report,2015 ATA Management Guidelines with Differentiated Thyroid Cancer
Index test:Differential RNA

Sponsors

Affililated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old, first-time operation; (2) The pathological diagnosis of thyroid micropapillary carcinoma was confirmed; (3) Patients voluntarily participated in the study with informed consent;

Exclusion criteria

Exclusion criteria: (1) Previous history of cervical radiation or secondary thyroid surgery; (2) The pathological types were nodular goiter, follicular carcinoma or medullary carcinoma, and other non-thyroid micropapillary carcinoma specimens; (3) The case data is incomplete and untraceable; (4) Patients refused to participate in the study;

Design outcomes

Primary

MeasureTime frame
Lateral cervical lymph node metastasis;—

Countries

China

Contacts

Public ContactLuo Dingcun

Affililated Hangzhou First People's Hospital, Zhejiang University School of Medicine

ldc65@163.com13732225858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026